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and 79 in the control group.
Study design
The study was a randomised controlled study that was conducted in 12 nursing homes. The 12 nursing homes, with a total of 1,705 residents, were matched in pairs on the basis of the total number of beds and the annual rate of influenza vaccination. For each matched pair, one nursing home was randomly assigned (by the toss of a coin) to the experimental nursing group, while the other was assigned to the control nursing group. The time horizon was unclear. No loss to follow-up was reported.
Analysis of effectiveness
The basis of the analysis was intention to treat. The health outcome measures used in the analysis were numerous. However, the main health outcomes were the influenza attack rate, the duration of the influenza outbreak, the rate of secondary complications, the rate and length of hospital stay, and the mortality rate. Infection prevention measures and infection control measures were documented and compared. The proportion of diagnostic tests ordered for influenza A virus and the median turnaround time for the test results were compared in the two groups. The average age, the gender ratio and the clinical symptoms at enrolment were not statistically different between the two groups.
Effectiveness results
The median influenza A virus attack rates were similar in the two groups, 154 per 1,000 residents for the experimental group versus 199 per 1,000 for the control group, (p=0.48). The duration of the influenza outbreak in the control group was significantly longer, 16 days versus 9 days, (p=0.03).
The overall mortality rate was identical in both groups, 8.8% versus 8.9%.
The number of hospitalised patients in the experimental group (n=8, 10%) was somewhat higher than in the control group (n=5, 6.3%), although this difference was not significant.
The rates for all of the other clinical outcomes were not significantly different between the two groups.
The patients enrolled in the experimental group were much more likely to have a diagnostic test ordered for influenza A virus than those in the control group, 98.8% versus 28.8%, (p<0.0001).
The median turnaround time for test results was 1 day (range: 1 -2) in the experimental group versus 5 days (range: 1 -20) in the control group, (Wilcoxon rank sum test, p=0.05).
